Is It Time To Reassess Insulet (PODD) After Recent Share Price Weakness [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
If you are wondering whether Insulet is offering fair value at its current share price, you are not alone in asking what the market is really pricing in. The stock recently closed at US$255.10, with returns of a 6.1% decline over 7 days, a 10.3% decline over 30 days, and a 9.8% decline year to date, which may have shifted how some investors see its risk and reward trade off. Recent coverage of Insulet has focused on its role in the diabetes care space and how the company is positioned within the broader healthcare sector, giving investors more context around its share price moves. This backdrop is important when thinking about whether the recent 8.4% 1 year decline and 13.6% 3 year decline reflect changing expectations or simply normal volatility. On our framework, Insulet currently scores 3 out of 6 on valuation checks , which sets up a closer look at how different valuation approaches compare and hints at an even more useful way of thinking about value that we will come to at
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding [Yahoo! Finance]Yahoo! Finance
- Insulet Launches Omnipod® 5 and Omnipod Discoverâ„¢ in the Middle East to Transform Diabetes CareBusiness Wire
- Insulet (NASDAQ:PODD) had its price target lowered by analysts at Stifel Nicolaus from $370.00 to $350.00. They now have a "buy" rating on the stock.MarketBeat
- Insulet Corporation (PODD): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Reasons Why Hedge Funds Favor Insulet Corp (PODD) [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 2/5/26 - Form SCHEDULE
- 2/3/26 - Form 8-K
- 1/6/26 - Form 4
- PODD's page on the SEC website